Byetta Pancreatitis LawsuitsJanuary 1, 2010
At this time our law firm is no longer accepting new cases involving this drug. This does not mean that you do not have a case; please seek a second opinion with local legal counsel to discuss your options.
The FDA has issued numerous warnings regarding Byetta side effects. Serious side effects from the use of Byetta may include acute pancreatitis, hemorrhagic pancreatitis or necrotizing pancreatitis. Pancreatitis is an inflammation of the pancreas that can cause bleeding, tissue damage and infection. The FDA warns that at least two people have died as a result of Byetta-associated pancreatitis. A severe case of pancreatitis can lead to the release of toxins and enzymes into the blood stream. These toxins can injure the heart, lungs, kidneys or other organs resulting in pancreatic death.
Byetta is made by Amylin Pharmaceuticals Inc, and marketed jointly by Amylin and Eli Lilly & Co. The drug was approved by the Food & Drug Administration (FDA) in 2005 to help type 2 diabetics better control blood sugar when other drugs were not adequate. While Byetta may lower blood glucose levels on its own, it can also be combined with other medications such as pioglitazone, metformin, sulfonylureas, and/or insulin (not FDA approved yet) to improve glucose control. The approved use of exenatide is with either sulfonylureas, metformin and thiazolinediones. Byetta is injected subcutaneously twice per day using a pre-filled pen device.
If you or a loved one were prescribed Byetta and have been diagnosed with serious side effects including acute pancreatitis, necrotizing pancreatitis or hemorrhagic pancreatitis, then you may have a legal right to file a Byetta pancreatitis lawsuit. Please contact our law firm to discuss your legal options. Your initial consultation with a Byetta lawyer about your potential case is free and confidential.© Willis Law Firm for Drug Attorneys. Replication strictly prohibited without written consent.